Dharmesh Kharwar Appointed As Independent Director At ENTOD Pharmaceuticals

Mumbai-headquartered ENTOD Pharmaceuticals has announced the appointment of Mr. Dharmesh Kharwar as a non-executive independent director. With a distinguished career that includes leadership roles at FDC Ltd, Johnson & Johnson, and MSD/Merck, Mr. Kharwar brings a wealth of knowledge in areas such as product development, manufacturing, regulatory compliance, quality control, and business growth. He also holds board positions in various public and private companies, leveraging his expertise across the chemical and biologics industries, including intellectual property and commercial strategy.

Mr. Dharmesh Kharwar’s extensive track record in spearheading innovation and fostering growth has seen him lead major initiatives, form global partnerships, and play a pivotal role in the development of chemical and biological therapies. His expertise in navigating regulatory landscapes and shaping market strategies positions him as a key asset to ENTOD Pharmaceuticals. ENTOD, a 47-year-old company, is renowned for its R&D focus in ENT, ophthalmology, and dermatology. With a portfolio exceeding 250 products, the company continues to make strides across multiple research and development branches.

Mr. Kharwar, excited about his appointment, stated, “I am honoured to join ENTOD Pharmaceuticals, a company that places a strong emphasis on being patient- and physician-centric. This focus has fueled its groundbreaking innovations for nearly five decades, and I am excited to contribute to its continued success.”

Nikkhil K Masurkar, CEO at ENTOD, said in a statement, “I am confident that Mr. Kharwar’s expertise and leadership will further strengthen our mission of delivering world-class cost-effective pharmaceutical solutions and raising the bar when it comes to research & innovation.”